C. Bustamante

发表

In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, a Potential Novel Compound for Treating against Trypanosoma cruzi

S. Robledo, M. J. Soares, R. Ochoa, 2022, Pathogens.

Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations

Rodrigo Ochoa, Carlos Muskus, Christian Bustamante, 2019, Journal of Computer-Aided Molecular Design.